Phase 1B/2 Study of PAC-1 and Entrectinib for Patients with Metastatic Uveal Melanoma

Learn more:

• https://clinicaltrials.gov/study/NCT04589832

Manuscripts/Articles: 

• Matthew Boudreau, Emily Tonogai, Claire Schane, Min X. Xi, James Fischer, Jayanthic Vijayakumar, Yanc Ji, Theodore Tarasow, Timothy Fan, Paul Hergenrother, Arkadiusz Dudek. The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma: MEL18-372. Melanoma Research, December 2023. See Abstract.